[1]
Alexa MEARA, Ruth CHAN, and Matthew HUSA, “Management Decisions for Rheumatoid Arthritis After Tumor Necrosis Factor Alpha Antagonist-Induced Lupus-Like Syndrome”, Archives of Rheumatology, vol. 31, no. 4, pp. 388–389, Dec. 2016.